MOLEAC

Moleac Pte Ltd is a biotechnology company based in Singapore, established in 2002. It specializes in the development and commercialization of natural medicines used in neurology, especially in the treatment of patients with the consequences of stroke, traumatic brain injury and neurodegenerative diseases. Her mission is to help patients regain functional independence and quality of life through innovative therapies.

Their most famous product is NeuroAiD™ II, a natural remedy that combines nine herbal extracts in capsule form. This product is available in more than 35 countries and is used to support neurological, motor and cognitive functions, resulting in a better quality of life. In Singapore, NeuroAiD™ II has been classified as a Chinese patent medicine by the Singapore Health Sciences Agency (HSA) and has been available since 2010.

Moleac prides itself on its approach based on scientific research and collaboration with experts in the field of neurology. Their research work includes more than 45 scientific papers since 2009, including pharmacological studies evaluating various properties of the product.